INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 35 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $176,248 | -3.7% | 187,000 | 0.0% | 0.00% | -20.0% |
Q3 2022 | $183,000 | +105.6% | 187,000 | +96.8% | 0.01% | +150.0% |
Q2 2022 | $89,000 | -6.3% | 95,000 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $95,000 | -3.1% | 95,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $98,000 | -1.0% | 95,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $99,000 | -1.0% | 95,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $100,000 | -5.7% | 95,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $106,000 | -0.9% | 95,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $107,000 | +2.9% | 95,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $104,000 | +11.8% | 95,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $93,000 | +16.2% | 95,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $80,000 | -13.0% | 95,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $92,000 | -79.5% | 95,000 | -82.3% | 0.00% | -66.7% |
Q3 2019 | $449,000 | -14.1% | 536,000 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $523,000 | +17.0% | 536,000 | +21.5% | 0.00% | +33.3% |
Q1 2019 | $447,000 | 0.0% | 441,000 | -29.4% | 0.00% | -25.0% |
Q4 2018 | $447,000 | -15.3% | 625,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $528,000 | -8.3% | 625,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $576,000 | +30.3% | 625,000 | +25.0% | 0.00% | +33.3% |
Q1 2018 | $442,000 | – | 500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |